Creative Biolabs is a top expert in lipid-based drug delivery systems, providing a unique range of liposome and LNP products including plain, fluorescent liposomes, drug-loaded liposomes, and liposomal vaccine or adjuvant.
| Product | Description | |
|---|---|---|
| LP-01 LNP-Cap 1 EGFP mRNA | This product is a LNP prepared with ionizable lipid (LP-01), helper lipid, cholesterol and PEGylated lipid, encapsulating EGFP mRNA. EGFP mRNA, a common fluorescence reporter, translates into enhanced green fluorescent protein, which exhibits an excitation wavelength of 488 nm and emission at 507 nm. The loaded EGFP mRNA is capped with the CAP 1 structure. It is only for research purposes. Group: Lipid nanoparticle. |  |
| LP-01 LNP-Cap 1 EGFP mRNA (5-moU) | This product is a LNP prepared with ionizable lipid (LP-01), helper lipid, cholesterol and PEGylated lipid, encapsulating EGFP mRNA. EGFP mRNA, a common fluorescence reporter, translates into enhanced green fluorescent protein, which exhibits an excitation wavelength of 488 nm and emission at 507 nm. The loaded EGFP mRNA is capped with the CAP 1 structure and modified with 5-methoxyuridine to enhance expression and reduce immunogenicity. It is only for research purposes. Group: Lipid nanoparticle. | |
| LP-01 LNP-Cap 1 EGFP mRNA (m1Ψ) | This product is a LNP prepared with ionizable lipid (LP-01), helper lipid, cholesterol and PEGylated lipid, encapsulating EGFP mRNA. EGFP mRNA, a common fluorescence reporter, translates into enhanced green fluorescent protein, which exhibits an excitation wavelength of 488 nm and emission at 507 nm. The loaded EGFP mRNA is capped with the CAP 1 structure and modified with N1-methyl-pseudouridine to enhance expression and reduce immunogenicity. It is only for research purposes. Group: Lipid nanoparticle. | |
| LP-01 LNP-Cap 1 Fluc mRNA | This product is a LNP prepared with ionizable lipid (LP-01), helper lipid, cholesterol and PEGylated lipid, encapsulating Firefly Luciferase mRNA. Firefly Luciferase mRNA, a fluorescence reporter, encodes an enzyme that catalyzes the oxidation of luciferin to oxyluciferin, producing bioluminescence. The loaded Firefly Luciferase mRNA is capped with the CAP 1 structure. It is only for research purposes. Group: Lipid nanoparticle. | |
| LP-01 LNP-Cap 1 Fluc mRNA (m1Ψ) | This product is a LNP prepared with ionizable lipid (LP-01), helper lipid, cholesterol and PEGylated lipid, encapsulating Firefly Luciferase mRNA. Firefly Luciferase mRNA, a fluorescence reporter, encodes an enzyme that catalyzes the oxidation of luciferin to oxyluciferin, producing bioluminescence. The loaded Firefly Luciferase mRNA is capped with the CAP 1 structure and modified with N1-methyl-pseudouridine to enhance expression and reduce immunogenicity. It is only for research purposes. Group: Lipid nanoparticle. | |
| LP-01 LNP-Cap 1 OVA mRNA | This product is a LNP prepared with ionizable lipid (LP-01), helper lipid, cholesterol and PEGylated lipid, encapsulating OVA mRNA. OVA(ovalbumin) is the predominant glycoprotein in egg whites and is known for its immunogenic properties, making it an ideal model antigen for studying immune responses. The loaded OVA mRNA is capped with the CAP 1 structure. It is only for research purposes. Group: Lipid nanoparticle. | |
| LP-01 LNP-EGFP mRNA (m1Ψ) | This product is a LNP prepared with ionizable lipid (LP-01), helper lipid, cholesterol and PEGylated lipid, encapsulating EGFP mRNA. EGFP mRNA, a common fluorescence reporter, translates into enhanced green fluorescent protein, which exhibits an excitation wavelength of 488 nm and emission at 507 nm. The loaded EGFP mRNA is modified with N1-methyl-pseudouridine to enhance expression and reduce immunogenicity. It is only for research purposes. Group: Lipid nanoparticle. | |
| LP-01 LNP-Empty | This product is a empty LNP prepared with LP-01 as the ionizable lipid and can be used as a negative control to determine the optimal mRNA delivery formulation. It is only for research purposes. Group: Lipid nanoparticle. | |
| LP-01 LNP-Fluc mRNA | This product is a DIR-labeled LNP prepared with ionizable lipid (ALC-0315), helper lipid, cholesterol and PEGylated lipid, encapsulating GFP mRNA. The GFP mRNA encodes the green fluorescent protein (GFP), a widely used marker for monitoring gene expression and transfection efficiency. It exhibits an excitation wavelength of 480 nm and emission at 510 nm. It is only for research purposes. Group: Lipid nanoparticle. | |
| LP-01 LNP-Fluc mRNA (m1Ψ) | This product is a LNP prepared with ionizable lipid (LP-01), helper lipid, cholesterol and PEGylated lipid, encapsulating Firefly Luciferase mRNA. Firefly Luciferase mRNA, a fluorescence reporter, encodes an enzyme that catalyzes the oxidation of luciferin to oxyluciferin, producing bioluminescence. The loaded Firefly Luciferase mRNA is modified with N1-methyl-pseudouridine to enhance expression and reduce immunogenicity. It is only for research purposes. Group: Lipid nanoparticle. | |
| LP-01 LNP-GFP mRNA LNP | This product is a LNP prepared with ionizable lipid (LP-01), helper lipid, cholesterol and PEGylated lipid, encapsulating GFP mRNA. The GFP mRNA encodes the green fluorescent protein (GFP), a widely used marker for monitoring gene expression and transfection efficiency. It exhibits an excitation wavelength of 480 nm and emission at 510 nm. It is only for research purposes. Group: Lipid nanoparticle. | |
| Lung Targeted ALC-0315 LNP-Fluc mRNA (m1Ψ) | This product is a multi-component LNP prepared from ALC-0315 as the ionizable lipid. It's specifically designed for targeted delivery of Firefly Luciferase mRNA to lung. Firefly Luciferase mRNA, a fluorescence reporter, encodes an enzyme that catalyzes the oxidation of luciferin to oxyluciferin, producing bioluminescence. The loaded Firefly Luciferase mRNA is modified with N1-methyl-pseudouridine to enhance expression and reduce immunogenicity. It is only for research purposes. Group: Lipid nanoparticle. | |
| Lung Targeted SM102 LNP-Fluc mRNA (m1Ψ) | This product is a LNP prepared from SM102 as the ionizable lipid and DOTAP as cationic lipid. It's specifically designed for targeted delivery of Firefly Luciferase mRNA to lung. Firefly Luciferase mRNA, a fluorescence reporter, encodes an enzyme that catalyzes the oxidation of luciferin to oxyluciferin, producing bioluminescence. The loaded Firefly Luciferase mRNA is modified with N1-methyl-pseudouridine to enhance expression and reduce immunogenicity. It is only for research purposes. Group: Lipid nanoparticle. | |
| Lutein Liposome | Lutein belongs to the oxygen-containing carotenoids and is a derivative of terpenoid compounds. It has a protective effect on vision, and has the ability to prevent cataracts, atherosclerosis, and enhance immunity. This product is a pre-formulated liposome encapsulating Lutein. It is only for research purposes. Group: Drug-loaded liposome. | |
| Mitoxantrone Liposome | Mitoxantrone is an anthracycline that enters the nucleus of the cell and binds to DNA, thereby inhibiting nucleic acid synthesis and mitosis, leading to cell death. This product is a pre-formulated liposome with mitoxantrone. It is only for research purposes and for the injection to laboratory animals. Group: Drug-loaded liposome. | |
| mRNA Lipofection Reagent (LNP) | This product is a universal transfection reagent based on LNPs, specifically designed for mRNA transfection in T cells. It has the advantages of high transfection rate, low cytotoxicity, good reproducibility, and simple operation. Please note that it is intended for research purposes only and is not suitable for clinical diagnosis or treatment. Group: Transfection reagents. | |
| Nucleic Acid Liposome | This liposome is a blank liposome and can be used as adjuvant. It enhances immune responses by electrostatically attaching nucleic acids and protecting them from degradation. It is only for research purposes. Group: Liposomal vaccine or adjuvant. | |
| Oleanolic Acid Liposome | Oleanolic Acid (OA) is a natural triterpenoid compound with poor water solubility. It is primarily used in the treatment of acute cholestatic hepatitis and chronic viral hepatitis. This product is a pre-formulated liposome encapsulating Oleanolic Acid. It is only for research purposes. Group: Drug-loaded liposome. | |
| Ornithine Aspartate Liposome | Ornithine aspartate is essential for the synthesis of urea and glutamine. This product is a pre-formulated liposome with ornithine aspartate. It is only for research purposes and for the injection to laboratory animals. Group: Drug-loaded liposome. | |
| Paclitaxel-Curcumin Liposome (PEGylated) | Paclitaxel (PTX) is a taxane drug extracted from Taxus brevifolia, widely used in the treatment of breast cancer, ovarian cancer, non-small cell lung cancer, and other malignancies. Curcumin is a polyphenolic compound with various pharmacological effects such as tumor, anti-inflammatory and antioxidant. This product is a pre-formulated liposome encapsulating Paclitaxel and Curcumin. It is only for research purposes. Group: Drug-loaded liposome. | |
| Paclitaxel Liposome | Paclitaxel (PTX) is a taxane drug extracted from Taxus brevifolia, widely used in the treatment of breast cancer, ovarian cancer, non-small cell lung cancer, and other malignancies. This product is a pre-formulated liposome encapsulating Tea Paclitaxel. It is only for research purposes. Group: Drug-loaded liposome. | |
| Plain ExoLiposome | The product is composed of lipids that are consistent with exosomes, which mimic the natural properties of exosomes with the easy modification properties of liposomes. Group: Exoliposome. | |
| Poly(I:C) Liposome | Poly(I:C) is a synthetic double-stranded RNA that induces the production of antigen-specific CD8+ T cells that are recognized by the TLR3 receptor. This liposome contains Poly(I:C) and can be used as adjuvant to effectively induce cellular and humoral immune responses. It is only for research purposes. Group: Liposomal vaccine or adjuvant. | |
| pRc/CMV HBS Liposome | This liposome contains pRc/CMV HBS, which increases the level of secretory immunoglobulin IgA. It is only for research purposes. Group: Liposomal vaccine or adjuvant. | |
| Quercetin Liposome | Quercetin is a natural flavonoid that is almost insoluble in water. It possesses antioxidant, lipid-lowering, and coronary artery dilation effects. This product is a pre-formulated liposome encapsulating quercetin. It is only for research purposes. Group: Drug-loaded liposome. | |
| Resveratrol Liposome | Resveratrol (RES) belongs to a class of natural polyphenols and plant toxins. It is widely involved in various signaling pathways such as inflammation, oxidative stress, cell apoptosis, mitochondrial dysfunction, and angiogenesis. This product is a pre-formulated liposome encapsulating Resveratrol. It is only for research purposes. Group: Drug-loaded liposome. | |
| Retinoic Acid-Gambogic Acid Liposome | Retinoic acid is an intermediate product of vitamin A metabolism. Gambogic acid is derived from the gamboge and is a protease activator and apoptosis inducer. This product is a pre-formulated composite liposome with retinoic acid and gambogic acid. It can induce apoptosis in tumor cells and exerts synergistic anti-tumor effects. It is only for research purposes. Group: Drug-loaded liposome. | |
| Retinoic Acid-Glycyrrhizic Flavone Liposome | Retinoic acid is an intermediate product of vitamin A metabolism. Glycyrrhizic flavone are compounds extracted from licorice that have corticosteroid-like effects. This product is a pre-formulated composite liposome with retinoic acid and glycyrrhizic flavone. It can be used for epithelial cell abnormalities such as hyperpigmentation and photoaging. It is only for research purposes. Group: Drug-loaded liposome. | |
| Retinoic Acid Liposome | Retinoic acid is an intermediate product of vitamin A metabolism, which can affect bone growth and promote metabolic effects such as epithelial cell proliferation, differentiation and keratolysis. This product is a pre-formulated liposome with vitamina acid. It is only for research purposes. Group: Drug-loaded liposome. | |
| Rhodamine DHPE Labeled ExoLiposome | The product is composed of lipids that are consistent with exosomes, which mimic the natural properties of exosomes with the easy modification properties of liposomes. Rhodamine DHPE is a glycerophosphoethanolamine lipid labeled with rhodamine. This product can be used in membrane fusion assays. Group: Exoliposome. | |
| Sirolimus Liposome | Sirolimus, a metabolite of AYBP44 (streptomyces hygroscopicus), is not only a low-toxicity antibiotic but also a novel immunosuppressant. This product is a pre-formulated liposome with sirolimus. It is only for research purposes. Group: Drug-loaded liposome. | |
| SM102 LNP-Cap 1 EGFP mRNA | This product is a LNP prepared with ionizable lipid (SM102), helper lipid, cholesterol and PEGylated lipid, encapsulating EGFP mRNA. EGFP mRNA, a common fluorescence reporter, translates into enhanced green fluorescent protein, which exhibits an excitation wavelength of 488 nm and emission at 507 nm. The loaded EGFP mRNA is capped with the CAP 1 structure. It is only for research purposes. Group: Lipid nanoparticle. | |
| SM102 LNP-Cap 1 EGFP mRNA (5-moU) | This product is a LNP prepared with ionizable lipid (SM102), helper lipid, cholesterol and PEGylated lipid, encapsulating EGFP mRNA. EGFP mRNA, a common fluorescence reporter, translates into enhanced green fluorescent protein, which exhibits an excitation wavelength of 488 nm and emission at 507 nm. The loaded EGFP mRNA is capped with the CAP 1 structure and modified with 5-methoxyuridine to enhance expression and reduce immunogenicity. It is only for research purposes. Group: Lipid nanoparticle. | |
| SM102 LNP-Cap 1 EGFP mRNA (m1Ψ) | This product is a LNP prepared with ionizable lipid (SM102), helper lipid, cholesterol and PEGylated lipid, encapsulating EGFP mRNA. EGFP mRNA, a common fluorescence reporter, translates into enhanced green fluorescent protein, which exhibits an excitation wavelength of 488 nm and emission at 507 nm. The loaded EGFP mRNA is capped with the CAP 1 structure and modified with N1-methyl-pseudouridine to enhance expression and reduce immunogenicity. It is only for research purposes. Group: Lipid nanoparticle. | |
| SM102 LNP-Cap 1 Fluc mRNA | This product is a LNP prepared with ionizable lipid (SM102), helper lipid, cholesterol and PEGylated lipid, encapsulating Firefly Luciferase mRNA. Firefly Luciferase mRNA, a fluorescence reporter, encodes an enzyme that catalyzes the oxidation of luciferin to oxyluciferin, producing bioluminescence. The loaded Firefly Luciferase mRNA is capped with the CAP 1 structure. It is only for research purposes. Group: Lipid nanoparticle. | |
| SM102 LNP-Cap 1 Fluc mRNA (m1Ψ) | This product is a LNP prepared with ionizable lipid (SM102), helper lipid, cholesterol and PEGylated lipid, encapsulating Firefly Luciferase mRNA. Firefly Luciferase mRNA, a fluorescence reporter, encodes an enzyme that catalyzes the oxidation of luciferin to oxyluciferin, producing bioluminescence. The loaded Firefly Luciferase mRNA is capped with the CAP 1 structure and modified with N1-methyl-pseudouridine to enhance expression and reduce immunogenicity. It is only for research purposes. Group: Lipid nanoparticle. | |
| SM102 LNP-Cap 1 OVA mRNA | This product is a LNP prepared with ionizable lipid (SM102), helper lipid, cholesterol and PEGylated lipid, encapsulating OVA mRNA. OVA(ovalbumin) is the predominant glycoprotein in egg whites and is known for its immunogenic properties, making it an ideal model antigen for studying immune responses. The loaded OVA mRNA is capped with the CAP 1 structure. It is only for research purposes. Group: Lipid nanoparticle. | |
| SM102 LNP-EGFP mRNA | This product is a LNP prepared with ionizable lipid (SM102), helper lipid, cholesterol and PEGylated lipid, encapsulating EGFP mRNA. EGFP mRNA, a common fluorescence reporter, translates into enhanced green fluorescent protein, which exhibits an excitation wavelength of 488 nm and emission at 507 nm. It is only for research purposes. Group: Lipid nanoparticle. | |
| SM102 LNP-EGFP mRNA (5-moU) | This product is a LNP prepared with ionizable lipid (SM102), helper lipid, cholesterol and PEGylated lipid, encapsulating EGFP mRNA. EGFP mRNA, a common fluorescence reporter, translates into enhanced green fluorescent protein, which exhibits an excitation wavelength of 488 nm and emission at 507 nm. The loaded EGFP mRNA is modified with 5-methoxyuridine to enhance expression and reduce immunogenicity. It is only for research purposes. Group: Lipid nanoparticle. | |
| SM102 LNP-EGFP mRNA (m1Ψ) | This product is a LNP prepared with ionizable lipid (SM102), helper lipid, cholesterol and PEGylated lipid, encapsulating EGFP mRNA. EGFP mRNA, a common fluorescence reporter, translates into enhanced green fluorescent protein, which exhibits an excitation wavelength of 488 nm and emission at 507 nm. The loaded EGFP mRNA is modified with N1-methyl-pseudouridine to enhance expression and reduce immunogenicity. It is only for research purposes. Group: Lipid nanoparticle. | |
| SM102 LNP-Empty | This product is a empty LNP prepared with SM102 as the ionizable lipid and can be used as a negative control to determine the optimal mRNA delivery formulation. It is only for research purposes. Group: Lipid nanoparticle. | |
| SM102 LNP-Fluc mRNA | This product is a LNP prepared with ionizable lipid (SM102), helper lipid, cholesterol and PEGylated lipid, encapsulating Firefly Luciferase mRNA. Firefly Luciferase mRNA, a fluorescence reporter, encodes an enzyme that catalyzes the oxidation of luciferin to oxyluciferin, producing bioluminescence. It is only for research purposes. Group: Lipid nanoparticle. | |
| SM102 LNP-Fluc mRNA (m1Ψ) | This product is a LNP prepared with ionizable lipid (SM102), helper lipid, cholesterol and PEGylated lipid, encapsulating Firefly Luciferase mRNA. Firefly Luciferase mRNA, a fluorescence reporter, encodes an enzyme that catalyzes the oxidation of luciferin to oxyluciferin, producing bioluminescence. The loaded Firefly Luciferase mRNA is modified with N1-methyl-pseudouridine to enhance expression and reduce immunogenicity. It is only for research purposes. Group: Lipid nanoparticle. | |
| SM102 LNP-GFP mRNA | This product is a LNP prepared with ionizable lipid (SM102), helper lipid, cholesterol and PEGylated lipid, encapsulating GFP mRNA. The GFP mRNA encodes the green fluorescent protein (GFP), a widely used marker for monitoring gene expression and transfection efficiency. It exhibits an excitation wavelength of 480 nm and emission at 510 nm. It is only for research purposes. Group: Lipid nanoparticle. | |
| Sodium Ferulate Liposome | Sodium ferulate is a nonpeptide endothelin receptor antagonist that is easily oxidized and susceptible to alkali, light and temperature. This product is a pre-formulated liposome with sodium ferulate. It is only for research purposes and for the injection to laboratory animals. Group: Drug-loaded liposome. | |
| Spleen-Targeted Lipofection Reagent (LNP) | This product is a transfection reagent based on LNPs, specifically designed for efficient delivery of mRNA, siRNA, DNA plasmid and other nucleic acid molecules to the spleen. It has the advantages of high transfection rate, low cytotoxicity, good reproducibility, and simple operation. Please note that it is intended for research purposes only and is not suitable for clinical diagnosis or treatment. Group: Transfection reagents. | |
| Spleen Targeted SM102 LNP-Fluc mRNA (m1Ψ) | This product is a LNP prepared from SM102 as the ionizable lipid and 18:1 PA as cationic lipid. It's specifically designed for targeted delivery of Firefly Luciferase mRNA to spleen. Firefly Luciferase mRNA, a fluorescence reporter, encodes an enzyme that catalyzes the oxidation of luciferin to oxyluciferin, producing bioluminescence. The loaded Firefly Luciferase mRNA is modified with N1-methyl-pseudouridine to enhance expression and reduce immunogenicity. It is only for research purposes. Group: Lipid nanoparticle. | |
| Squalene Liposome | The liposome contains squalene, which can be used as adjuvant to enhance the immune response. It is only for research purposes. Group: Liposomal vaccine or adjuvant. | |
| Tamoxifen Liposome | Tamoxifen (TAM) competes with estrogen to bind to the estrogen receptor (ER), thereby inhibiting the proliferation of breast cancer cells. This product is a pre-formulated liposome encapsulating Tamoxifen. It is only for research purposes. Group: Drug-loaded liposome. | |
| T cells Targeted SM102 LNP-EGFP mRNA (m1Ψ) | This product is a LNP prepared from SM102 as the ionizable lipid and modified with CD3 antibody. It's specifically designed for targeted delivery of EGFP mRNA to CD3+ T cells. EGFP mRNA, a common fluorescence reporter, translates into enhanced green fluorescent protein, which exhibits an excitation wavelength of 488 nm and emission at 507 nm. The loaded EGFP mRNA is modified with N1-methyl-pseudouridine to enhance expression and reduce immunogenicity. It is only for research purposes. Group: Lipid nanoparticle. | |
| Tea Polyphenol Liposome | Tea polyphenol (TP) is a polyphenolic compound extracted from tea leaves, known for their antioxidant, antimicrobial, anticancer, and lipid-lowering effects. This product is a pre-formulated liposome encapsulating Tea Polyphenol. It is only for research purposes. Group: Drug-loaded liposome. | |
| Tofacitinib Citrate Liposome | Tofacitinib Citrate (TOF) is a JAK3 inhibitor that achieves efficacy in treating rheumatoid arthritis by inhibiting the intracellular target Janus kinases (JAKs). This product is a pre-formulated liposome encapsulating Tofacitinib Citrate. It is only for research purposes. Group: Drug-loaded liposome. | |
| Topotecan Hydrochloride Liposome (PEGylated) | Topotecan Hydrochloride (TPT) is a semi-synthetic derivative of the plant alkaloid camptothecin (CPT) with cytotoxic properties. Like other drugs in the CPT family, TPT is a specific inhibitor of topoisomerase I, causing lethal DNA damage in the S phase of mitosis. Liposome preparation and anti-tumor activity research. This product is a pre-formulated liposome encapsulating Topotecan Hydrochloride. It is only for research purposes. Group: Drug-loaded liposome. | |
| Triptolide Liposome (PEGylated) | Triptolide (TP) is an epoxy diterpene lactone isolated from Tripterygium wilfordii Hook. f., which has been shown to inhibit the proliferation of hepatocellular carcinoma. This product is a pre-formulated liposome encapsulating Triptolide. It is only for research purposes. Group: Drug-loaded liposome. | |
| Universal mRNA Lipofection Reagent (LNP) | This product is a universal transfection reagent based on LNPs, designed specifically for delivering mRNA. It is suitable for transfection of eukaryotic cells such as HEK293T, WRL-68, HFL-1, A549, MCF7, Capan-2 cells, etc. It has the advantages of high transfection rate, low cytotoxicity, good reproducibility, and simple operation. Please note that it is intended for research purposes only and is not suitable for clinical diagnosis or treatment. Group: Transfection reagents. | |
| Universal siRNA Lipofection Reagent (LNP) | This product is a universal transfection reagent based on LNPs, designed specifically for delivering siRNA. It is suitable for transfection of eukaryotic cells such as HEK293T, WRL-68, HFL-1, A549, MCF7, Capan-2 cells, etc. It has the advantages of high transfection rate, low cytotoxicity, good reproducibility, and simple operation. Please note that it is intended for research purposes only and is not suitable for clinical diagnosis or treatment. Group: Transfection reagents. | |
| Vincristine Sulfate Liposome | Vincristine sulfate is in the vinca alkaloid family that exerts its cell cycle-specific antitumor effects by affecting spindle microtubule formation through inhibition of microtubule protein polymerization. This product is a PEGylated pre-formulated liposome with vincristine sulfate. It is only for research purposes. Group: Drug-loaded liposome. | |
| Vinflunine Liposome | Vinflunine is a novel fluorinated vinca alkaloid derivative that exerts antitumor effects by inhibiting the cell proliferation of microtubule proteins. This product is a PEGylated pre-formulated liposome with vinflunine ditartrate. It is only for research purposes. Group: Drug-loaded liposome. | |
| Vinorelbine Liposome | Vinorelbine is in the vinca alkaloid family, which is used in the treatment of non-small cell lung cancer. This product is a PEGylated pre-formulated liposome with vinorelbine bitartrate. It is only for research purposes. Group: Drug-loaded liposome. | |
| Vitamin P4 Liposome | Vitamin P4, also known as Troxerutin, inhibits platelet aggregation, prevents thrombus formation, improves blood circulation, increases capillary resistance, treats acute ischemic brain injury, and helps improve certain vascular disorders in the body. This product is a pre-formulated liposome encapsulating Vitamin P4. It is only for research purposes. Group: Drug-loaded liposome. | |
| Zoledronic Acid Liposome | Zoledronic acid (ZOL) is a nitrogen-containing bisphosphonate with high water solubility that can inhibit bone resorption, and it is used in the treatment of malignancy-induced hypercalcemia. This product is a pre-formulated liposome encapsulating Zoledronic Acid. It is only for research purposes. Group: Drug-loaded liposome. | |
Our database is helping our users find suppliers everyday.
